- Home
- BKE vs VERA Comparison
BKE vs VERA Comparison
Compare BKE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKE | VERA |
|---|---|---|
| Founded | 1948 | 2016 |
| Country | United States | United States |
| Employees | N/A | 339 |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.0B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BKE | VERA |
|---|---|---|
| Price | $41.95 | $40.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $53.00 | ★ $81.30 |
| AVG Volume (30 Days) | 491.0K | ★ 1.8M |
| Earning Date | 05-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.96% | N/A |
| EPS Growth | ★ 6.43 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | ★ $1,297,835,000.00 | N/A |
| Revenue This Year | $5.10 | N/A |
| Revenue Next Year | $4.99 | $472.48 |
| P/E Ratio | $45.86 | ★ N/A |
| Revenue Growth | ★ 6.58 | N/A |
| 52 Week Low | $40.93 | $19.07 |
| 52 Week High | $61.69 | $56.05 |
Technical Indicators
Market Signals| Indicator | BKE | VERA |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 65.05 |
| Support Level | N/A | $40.87 |
| Resistance Level | $45.81 | $42.77 |
| Average True Range (ATR) | 1.34 | 2.16 |
| MACD | -0.00 | 0.83 |
| Stochastic Oscillator | 25.56 | 71.66 |
Price Performance
Historical ComparisonAbout BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.